Sun Pharma Advanced Research Company Limited

Informe acción NSEI:SPARC

Capitalización de mercado: ₹66.4b

Sun Pharma Advanced Research Dirección

Dirección controles de criterios 1/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Anilkumar Raghavan

Chief Executive Officer (CEO)

₹69.6m

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEO10.6yrs
Participación del CEOn/a
Permanencia media de la dirección1.2yrs
Promedio de permanencia en la Junta Directiva7.5yrs

Actualizaciones recientes de la dirección

Recent updates

Sun Pharma Advanced Research (NSE:SPARC) Is In A Good Position To Deliver On Growth Plans

Jan 17
Sun Pharma Advanced Research (NSE:SPARC) Is In A Good Position To Deliver On Growth Plans

Sun Pharma Advanced Research Company Limited's (NSE:SPARC) Business Is Trailing The Industry But Its Shares Aren't

Nov 14
Sun Pharma Advanced Research Company Limited's (NSE:SPARC) Business Is Trailing The Industry But Its Shares Aren't

Is Sun Pharma Advanced Research (NSE:SPARC) Using Too Much Debt?

Sep 05
Is Sun Pharma Advanced Research (NSE:SPARC) Using Too Much Debt?

Here's Why We're Not At All Concerned With Sun Pharma Advanced Research's (NSE:SPARC) Cash Burn Situation

Jun 27
Here's Why We're Not At All Concerned With Sun Pharma Advanced Research's (NSE:SPARC) Cash Burn Situation

Is Sun Pharma Advanced Research (NSE:SPARC) A Risky Investment?

Nov 23
Is Sun Pharma Advanced Research (NSE:SPARC) A Risky Investment?

If You Had Bought Sun Pharma Advanced Research's (NSE:SPARC) Shares Three Years Ago You Would Be Down 57%

Feb 08
If You Had Bought Sun Pharma Advanced Research's (NSE:SPARC) Shares Three Years Ago You Would Be Down 57%

Do Institutions Own Sun Pharma Advanced Research Company Limited (NSE:SPARC) Shares?

Dec 14
Do Institutions Own Sun Pharma Advanced Research Company Limited (NSE:SPARC) Shares?

CEO

Anilkumar Raghavan (56 yo)

10.6yrs

Permanencia

₹69,608,000

Compensación

Mr. Anilkumar Raghavan has been the Chief Executive Officer of Sun Pharma Advanced Research Company Limited since April 24, 2014. Mr. Raghavan is a senior pharmaceutical services executive with significant...

Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Anilkumar Raghavan
Chief Executive Officer10.6yrs₹69.61msin datos
Anup Rathi
Chief Financial Officerless than a yearsin datossin datos
Nitin Dharmadhikari
Chief Operating Officerless than a yearsin datossin datos
Jaydeep Issrani
Senior General Manager of Business Developmentno datasin datossin datos
Kajal Damania
Company Secretary & Compliance Officer1.2yrssin datossin datos
Shanta Gupta
Chief Human Resource Officer4.8yrssin datossin datos
Siu-Long Yao
Head Clinical Developmentless than a yearsin datossin datos
Nitin Damle
Chief Innovation Officerno datasin datossin datos
Yashoraj Zala
Head of Drug Delivery Systemsno datasin datossin datos
Vikram Ramanathan
Head of Preclinical Development5.6yrssin datossin datos
Venkata Palle
Global Head of Drug Discovery & Preclinical Development1.7yrssin datossin datos
Shravanti Bhowmik
VP & Head Operations Managementless than a yearsin datossin datos

1.2yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de SPARC no se considera experimentado ( 1.2 años antigüedad media), lo que sugiere un nuevo equipo.

Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Dilip Shanghvi
Chairman18.7yrs₹390.00k19.06%
₹ 12.6b
Robert Jay Spiegel
Independent Director4.4yrs₹630.00ksin datos
Bhavna Doshi
Independent Director10.1yrs₹660.00ksin datos
Thennati Rajamannar
Non-Executive Non-Independent Director17.4yrs₹300.00k0.011%
₹ 7.3m
Vidhi Shanghvi
Additional Non-Executive Non-Independent Directorless than a yearsin datossin datos
Ferzaan Engineer
Independent Director7.5yrs₹630.00ksin datos
Mark Simon
Member of Advisory Board3.9yrs₹570.00ksin datos

7.5yrs

Permanencia media

66yo

Promedio de edad

Junta con experiencia: La junta directiva de SPARC se considera experimentada (7.5 años de antigüedad promedio).